FDA Investigator James P Mcevoy

James P Mcevoy has inspections in 12 countries as of 19 Oct 2023. James P Mcevoy has collaborated with a combinined 4331 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
369
Last Inspection Date:
19 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Poland, Denmark, Germany, United Kingdom of Great Britain and Northern Ireland, Norway, Netherlands, France, New Zealand, Canada, Italy, Spain
Co-Investigator(s):
Abdellah El Hajjam, Alan D Centi, Albert A Salvador, Alfred Puglia, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Anita R Michael, Ann Marie Karnick, Ann Marie Montemurro, Ann Marie Schofield, Anthony A Charity, Arthur G Hurst, Audrey Thereset Uy, Azza Talaat, Benton M Ketron, Bill Tacket, Jr, Brandi L Garbutt, Brandon J Brookens, Brandon M Kurjanowicz, Brian D Young, Brian R Yaun, Brian S Keefer, Calvin W Edwards, Cara M Minelli, Carrie L Doupnik, Cary Greene, CDR Michael J Mero, Celia L Hutchinstein, Chamberlain, Charles E Idjagboro, Charles R Bonapace, PhD, Ching Jeyg Chang, Christina K Theodorou, Colleen M Damon, Craig A Garmendia, Craig D Zagata, Crayton Lee, Crystal A Harlan, Cynthia F Kleppinger, MD, Cynthia White, Daniel T Lee, Daniel W Johnson, Darlene C Plank Turlington, Dauksism, David A Oluwo, David J Hafner, David L Pearce, Dawn C Olenjack, Dawn D Aiello, Deborah G Haney Cozzone, Deborah H Cozzone, Debra J Bennett, Denise M Digiulio, Dennis L Doupnik, Derek S Dealy, Diane Cvan Leeuwen, Don H Bark, PhD, Donald W Myrick, Donyel M Jones, Dougherty, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Edward P Potter, Edwin L Hobbs, Eileen T Monaghan, Ele Ibarra Pratt, RN, MPH, Emilio Z Azukwu, Eric L Vangraafeiland, Eric S Myskowski, Erika M Wilkerson, Ethan P Stegman, Frank W Perrella, Gabrielle J Swain, Gayle S Lawson, Gene R Gunn, George Pyramides, Gerald W Kopp, Gess, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Helen B Ricalde, Howard B Rabinovitch, Jaes P Mcevoy, James L Dunnie, Jr, James M Kewley, James M Mason, James M Odonnell, James P Meevoy, Jeannie R Mayberry, Jeen S Min, Jeffrey A Sommers, Jessica M Monteiro, John D Jaworski, John P Mistler, Jonee J Mearns, Jose A Cruz, Jose Acruz Gonzalez, Joseph Brady, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Joshua C Schafer, Judith A Paterson, Judith Paterson, Julianne C Mccullough, Julie M Anbarchian, Justin A Hefferman, Justin B Holder, Karen A Briggs, Karen M Cooper, Karyn M Campbell, Katelyn Astaub Zamperini, Kathryn A Krentz, Kelly N Kerr, Kendra L Brooks, Kim G Campbell, Kimberly A Dux, Kip J Hanks, Kish Bolden, Kristen D Evans, Kristina Conroy, Kristina J Donohue, Kristina L Conroy, Kyle D Covill, Kyle S Hobson, Lakecha N Lewis, Latorie S Jones, Laurie A Haxel, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Leslie K Ball, MD, Linda M Hoover, Linda M Ross, Linda S Mattingly, Lisa B Orr, Lisa M Bellows, Lloyd A Kinzel, Lori A Rose, LT John M Mastalski, LTJG Bradley E Benasutti, LTJG Lauren N Shade, Luis A Dasta, Magdi A Ali, Marc A Jackson, Jr, Marcelo O Mangalindan, Jr, Maria A Reed, Martha Sullivan Myrick, Mary E Storch, Mary R Kirker, Mastalskij, Matthew C Watson, Matthew R Noonan, Maureen A Duckworth, Maureen A Wentzel, Maureen Maureen, Mawreen A Awkworth, Meena Bansal Gupta, PhD, Megan M Lauff, Melissa M Dauksis, Melissa M Schafer, Meredith L Sheridan, Michael A Taylor, Michael E Maselli, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael Rosner, Michele L Obert, Michele M Falchek, Miguel A Martinez, Mike M Rashti, Mizanne E Lewis, Monica E Caphart, Mpris Inspector, Mra Mcculloughj, Myrick, Nadeem I Chaudhry, Nancy G Schmidt, Nancy L Rose, Nancy M Lazzari, Nikisha M Bolden, Nilufer Tampal, PhD, O'meara, Pamela M Tremarki, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Princess R Campbell, Raffi B Papazian, Ralph J Schmid, Ramanda C Gregory, Raymond L Cheung, Richard W Berning, Robert C Steyert, Ronald A Stokes, Ronald T Colucci, Roy R Rinc, Russell J Glapion, Russell P Vandermark, Ruth A Oni, Sarah K Graham, Sarah K Lemin, Sean D Duke, Sean Y Kassim, PhD, Seng Ching Hwang, Sharon K Thoma, PharmD, Sharon L Matson, Sharon Mills, Shelley L Waring, Sherri J Liu, Shusheen A Alexander, Sierra M Shockley, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, State Agency, Stephanie Mangigian, MS/OSH, RN, Steven E Kane, Sullivanm, Susan F Laska, MS, Suzanne M Healy, Tahseen Mirza, Tammy L Chavis, Tania E Vizcaino, Teigan M Mule, Tekalign Wondimu, Temar Q Williams, Thomas E Friel, Timothy T Kapsala, Todd J Maushart, Tonya O Corbin, Travers, Travis R Hunt, Valerie C Reed, Valerie G Vallely, Van Cliff, Vlada Matusovsky, Whitney S Reynolds, William C Brenneman, Xinyi Hui, Yessika Mashinski, Yvonne C Mcknight, Yvonne C Wood

James P Mcevoy's Documents

Publish Date Document Type Title
February, 2012 FDA 483 Discovery Laboratories, Inc. - Form 483, 2012-02-24
June, 2016 EIR PAREXEL International GmbH - EIR, 2016-06-23
May, 2018 FDA 483 Alexander Perl, MD - Form 483, 2018-05-18
February, 2006 EIR Gupta, Arvind K., M.D. - EIR, 2006-02-06
June, 2017 FDA 483 Giovanni Martinelli, M.D. - Form 483, 2017-06-09
November, 2014 FDA 483 Marcela V. Maus, M.D. - Form 483, 2014-11-17
May, 2003 FDA 483 InKine Pharmaceutical Co., Inc. - Form 483, 2003-05-28
December, 2005 EIR ICON Clinical Research - EIR, 2005-12-20
February, 2017 EIR Janssen Research & Development, LLC - EIR, 2017-02-27
July, 2014 EIR ReSearch Pharmaceutical Services, Inc. - EIR, 2014-07-17
April, 2009 FDA 483 Phibro Animal Health Corporation - Form 483, 2009-04-02
February, 2006 FDA 483 Gupta, Arvind K., M.D. - Form 483, 2006-02-06
January, 2009 EIR OraSure Technologies, Inc. - EIR, 2009-01-27
September, 2003 EIR Johnson & Johnson Pharmaceutical Research & Development, LLC - EIR, 2003-09-10
July, 2003 EIR Pfizer, Inc. - EIR, 2003-07-31
August, 2015 EIR Janssen Research & Development, LLC - EIR, 2015-08-19
November, 2014 EIR Noelle V. Frey, M.D. - EIR, 2014-11-12
September, 2003 EIR Charles River Laboratories Inc. - EIR, 2003-09-04
December, 2006 FDA 483 Paul McCabe - Form 483, 2006-12-12
April, 2005 EIR Fisher Clinical Services Inc. - EIR, 2005-04-06
August, 2012 EIR Sharp Packaging Services, LLC - EIR, 2012-08-10
April, 2009 EIR Phibro Animal Health Corporation - EIR, 2009-04-02
May, 2003 EIR UPMC Susquehanna - EIR, 2003-05-02
May, 2003 EIR InKine Pharmaceutical Co., Inc. - EIR, 2003-05-28
May, 2003 FDA 483 Response InKine Pharmaceutical Co., Inc. - Form 483R, 2003-06-16
December, 2003 EIR Johnson & Johnson Consumer Inc. - EIR, 2003-12-19
August, 2013 EIR Pfizer, Inc. - EIR, 2013-08-14
December, 2017 FDA 483 Kurt Barnhart, MD - Form 483, 2017-12-15
November, 2014 FDA 483 Noelle V. Frey, M.D. - Form 483, 2014-11-12
April, 2000 FDA 483 PMC Isochem - Form 483, 2000-04-28
October, 2017 EIR Dr. Albert Maguire. Clinical Inv. - EIR, 2017-10-20
November, 2004 EIR Discovery Laboratories, Inc. - EIR, 2004-11-10
May, 2017 FDA 483 Maryl Kreider, M.D. - Form 483, 2017-05-01
April, 2000 EIR PMC Isochem - EIR, 2000-07-13
March, 2013 FDA 483 Dr. Joe O'Sullivan, Cancer Centre, Belfast City Hospital - Form 483, 2013-03-08
February, 2017 FDA 483 Philadelphia FIGHT IRB - Form 483, 2017-02-02
November, 2014 EIR Marcela V. Maus, M.D. - EIR, 2014-11-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more